Under DMD conditions, these organelles undergo significant reprogramming, leading to reduced ATP levels in skeletal muscle in both DMD patients and dystrophin-deficient animal models, as well as a significant decrease in the ability to accumulate excess calcium ions [4,5,6,7,8,9]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.